Clinical trials
ECMO clinical trials
Below are recruiting ecmo clinical trials, each written for real people, not researchers. We’re tracking 71 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04709432Recruiting
Study of ECMO care for children in China
This study looks at children (ages 1 day to 18 years) in mainland China who were treated with ECMO during the past 10 years. It aims to understand how ECMO was used and how care outcomes may have differed for children.
Shanghai, Shanghai MunicipalityAges 1 day–18 years - NCT04445909Recruiting
Continuous skin carbon dioxide monitoring in heart-lung bypass patients
This study checks whether a sensor placed on the skin can reliably measure carbon dioxide levels in people who need VA-ECMO, a kind of temporary heart-lung support. It aims to help doctors monitor breathing and circulation more accurately while you’re on this support.
ViennaAges 18–90 - NCT03948048Recruiting
ECMO timing study for children with hard-to-treat septic shock
This trial looks at whether and when a heart-lung machine called ECMO should be used in children whose septic shock is not responding to standard treatment. It may help doctors choose the best timing to improve survival and recovery in the PICU.
ShanghaiAges 4 weeks–18 years - NCT05155904Recruiting
Study outcomes for adults on VA ECMO
This study looks at the results (outcomes) for adults who are receiving VA ECMO, a heart-lung life support machine. The goal is to better understand how patients do while on this type of support.
AmiensAges 18 years+ - NCT05698628Recruiting
Timing strategies to protect legs during peripheral ECMO
This trial studies whether an “early” or more “conservative” approach to improving blood flow to the leg can prevent limb damage during a type of heart-lung machine called peripheral VA-ECMO. It may help reduce the risk of poor leg blood flow (ischemia) in people with severe heart failure-related shock.
SeoulAges 19 years+ - NCT03793257Recruiting
ECMO patient registry for adults in Australia and New Zealand
This is a research registry for adults who need a breathing and/or heart support machine called ECMO while in the hospital. It collects information to better understand who receives ECMO and how patients do over time.
Canberra, Australian Capital TerritoryAges 18 years+ - NCT04158479Recruiting
Registry for people on ECMO life support
This registry collects information about people who are placed on ECMO, a heart-lung machine used to support breathing and/or circulation. It may help doctors better understand who benefits and how to manage ECMO in the future.
Beijing, Beijing MunicipalityAges Any age - NCT06400797Recruiting
ECMO patient outcomes and quality of life study
This study follows people who are on ECMO (a machine that supports heart and lung function) to see how they do and what their quality of life is like afterward. It helps doctors learn more about long-term recovery.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT07807046Recruiting
Guided atracurium dosing in ICU patients
This trial tests whether using a device to guide the dosing of atracurium (a muscle relaxant) improves outcomes in critically ill ICU patients who need this medication for more than 48 hours. It focuses on patients with severe lung or heart conditions, such as ARDS or ECMO support.
New Taipei CityAges 20 years+ - NCT07726940Recruiting
A Study of Immune Responses and ECMO in Severe Lung Injury
This study looks at how the immune system and ECMO (a machine that helps oxygenate blood) can improve outcomes for people with moderate to severe ARDS. If you join, researchers will monitor your condition and treatment to find better ways to manage this serious lung problem.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06662084Recruiting
Liver enzyme function in people with cardiogenic shock on heart pumps
This study tests whether your liver’s drug-processing enzymes (CYP) work normally during cardiogenic shock when you are on a heart pump like ECMO or Impella®. The goal is to help doctors choose the right medicines for you.
GenevaAges 18 years+ - NCT06442267RecruitingPhase 4
Comparing blood thinners for ECMO support
This trial compares three different blood thinners (heparin, argatroban, and enoxaparin) used during ECMO support. It aims to find the safest and most effective way to prevent blood clots while on ECMO.
Vienna, State of ViennaAges 18 years+ - NCT07584187Recruiting
Brain monitoring during emergency heart-lung support treatment
This study uses special monitoring devices to measure brain activity in patients receiving emergency mechanical heart-lung support (ECMO). The goal is to help doctors quickly predict which patients might recover neurologically and guide early treatment decisions.
ViennaAges 18 years+ - NCT04754854Recruiting
Testing less blood recirculation during veno-venous ECMO
This trial studies whether a change in how a veno-venous ECMO machine works can reduce “blood recirculation” (blood returning to the circuit too quickly) in people with severe lung failure. It may help improve oxygen levels in adults whose ARDS is not responding to standard treatment.
BerlinAges 18 years+ - NCT06766006Recruiting
Heart-lung machine left ventricle unloading study
This study looks at how to best relieve pressure on the heart while a heart-lung machine is helping to pump blood. It includes anyone who needs this support.
MaastrichtAges 1 day–80 years - NCT06792643RecruitingPhase 2
Cangrelor for heart attack patients on heart-lung support
This trial tests whether adding a fast-acting anti-clotting drug (cangrelor) helps people having a massive heart attack who need a heart-lung machine (VA-ECMO). The goal is to see if it reduces clotting risks without causing dangerous bleeding.
Milan, ItalyAges 18 years+ - NCT07334457Recruiting
Platelet Changes While on ECMO Support
This study looks at how blood cells called platelets change in people who are on a heart-lung machine (ECMO) in the ICU. It aims to better understand how the body responds to this support.
StrasbourgAges 18 years+ - NCT06862700Recruiting
Less vasopressors for heart shock on ECMO
This trial is studying whether using less of the medicines that raise blood pressure (vasopressors) can help people with severe heart failure who are on a heart-lung machine (ECMO) survive. It may answer if a gentler approach is safer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05132387Recruiting
Out-of-hospital cardiac arrest registry using automatic CPR
This study records information about people who suffer an out-of-hospital cardiac arrest and receive automatic chest compressions. It focuses on specific heart rhythms and emergency timing, which may help improve future emergency treatment.
WroclawAges 18–60 - NCT07193719RecruitingPhase 1/Phase 2
Personalized breathing support for kids after heart surgery
This study tests a personalized breathing technique to improve lung function and heart performance in children who have had heart surgery or are on ECMO. The goal is to find the best way to open up the lungs safely.
BerlinAges birth–18 years - NCT07113769Recruiting
Biomarkers and platelets in CPR patients
This trial is studying the blood biomarkers and platelet characteristics in patients who receive CPR and are then placed on a heart-lung bypass machine (ECPR). It aims to understand how these biological markers relate to patient outcomes.
Zhengzhou, HenanAges 18 years+ - NCT05717218Recruiting
Testing special breathing monitoring during VV-ECMO in ARDS
This trial checks whether a special “breathing sensor belt” that watches breathing in real time can be used safely in adults with severe lung failure (ARDS) who are on a machine called VV-ECMO. It may help the care team better monitor ventilation while you’re critically ill.
ParisAges 18 years+ - NCT07053618Recruiting
Heart pump support for high-risk heart procedures
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Beijing, Beijing MunicipalityAges 18–90 - NCT07041086Recruiting
Prehospital ECMO for cardiac arrest
This trial tests whether giving ECMO (a heart-lung machine) to people in cardiac arrest before they reach the hospital can improve survival. It might be an option if you had a witnessed heart attack and received CPR quickly.
Ostrava, Moravian-Silesian RegionAges 18–70
Hear when a new ECMO trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ecmo?
- Yes. Clin2 currently lists 71 recruiting ecmo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ecmo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ecmo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.